# Endo USA Inc., a Keenova Therapeutics trials: 107 (2026)

ClinicalTrials.gov lists 107 trials with Endo USA Inc., a Keenova Therapeutics Company as lead sponsor, 2 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Endo USA Inc., a Keenova Therapeutics Company: 107 rows for $5.35, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/endo-usa-inc-a-keenova-therapeutics-company

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 107
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 107, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 29, 2026 | NCT07846280 | Study to Assess the Long-term Safety of KN3835 in the Treatment and Retreatment of Flexible/Semi-Flexible Hammertoe (HMT) | Endo USA Inc., a Keenova Therapeutics Company | Phase 3 | Recruiting | Flexible Hammertoe, Semi-flexible Hammertoe | 470 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07846280) |
| August 12, 2026 | NCT07759362 | Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT) | Endo USA Inc., a Keenova Therapeutics Company | Phase 3 | Recruiting | Flexible Hammertoe, Semi-flexible Hammertoe | 554 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759362) |
| December 13, 2023 | NCT06169319 | A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA) | Endo USA Inc., a Keenova Therapeutics Company | Phase 2 | Completed | Plantar Fasciitis | 231 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06169319) |
| November 30, 2023 | NCT06151197 | Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease) | Endo USA Inc., a Keenova Therapeutics Company | Phase 3 | Completed | Plantar Fibromatosis, Ledderhose Disease | 436 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06151197) |
| May 26, 2023 | NCT05877066 | Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture | Endo USA Inc., a Keenova Therapeutics Company | Observational | Terminated | Dupuytren's Contracture | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05877066) |
| May 24, 2023 | NCT05873595 | Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease | Endo USA Inc., a Keenova Therapeutics Company | Observational | Terminated | Peyronie's Disease | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05873595) |
| June 15, 2022 | NCT05419505 | Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks | Endo USA Inc., a Keenova Therapeutics Company | Phase 2 | Completed | Edematous Fibrosclerotic Panniculopathy, Cellulite | 91 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05419505) |
| February 24, 2022 | NCT05254457 | Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis | Endo USA Inc., a Keenova Therapeutics Company | Phase 3 | Completed | Plantar Fibromatosis | 145 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05254457) |
| February 21, 2022 | NCT05249257 | Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity | Endo USA Inc., a Keenova Therapeutics Company | Observational | Completed | Cellulite, Laxity; Skin, Edematous Fibrosclerotic Panniculopathy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05249257) |
| December 9, 2021 | NCT05152173 | Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis | Endo USA Inc., a Keenova Therapeutics Company | Phase 2 | Completed | Plantar Fibromatosis | 176 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05152173) |
| December 23, 2020 | NCT04681027 | Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children | Endo USA Inc., a Keenova Therapeutics Company | Phase 3 | Suspended | Chronic Pain, Postsurgical Pain | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04681027) |
| December 22, 2020 | NCT04680156 | Long-term Follow-up Durability (Efficacy) Study of EN3835 for the Treatment of AC of the Shoulder (Frozen Shoulder) | Endo USA Inc., a Keenova Therapeutics Company | Observational | Terminated | Adhesive Capsulitis, Frozen Shoulder | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04680156) |
| December 21, 2020 | NCT04677712 | Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite | Endo USA Inc., a Keenova Therapeutics Company | Phase 4 | Completed | Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04677712) |
| October 8, 2020 | NCT04580303 | CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques | Endo USA Inc., a Keenova Therapeutics Company | Phase 2 | Completed | Edematous Fibrosclerotic Panniculopathy, Cellulite, Laxity; Skin | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04580303) |
| August 3, 2020 | NCT04496167 | Safety and Efficacy of EN3835 in Participants With Frozen Shoulder | Endo USA Inc., a Keenova Therapeutics Company | Phase 2 | Completed | Adhesive Capsulitis, Frozen Shoulder | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04496167) |
| July 2, 2020 | NCT04456296 | A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism | Endo USA Inc., a Keenova Therapeutics Company | Phase 4 | Completed | Hypogonadism, Hypogonadism, Male, Hypogonadotropic Hypogonadism | 673 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04456296) |
| May 8, 2020 | NCT04381117 | Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH) | Endo USA Inc., a Keenova Therapeutics Company | Observational | Completed | Edematous Fibrosclerotic Panniculopathy | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04381117) |
| January 22, 2020 | NCT04236635 | Histopathology Following CCH Injection | Endo USA Inc., a Keenova Therapeutics Company | Phase 2 | Completed | Characteristics of Subcutaneous Tissue | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04236635) |
| December 24, 2019 | NCT04209530 | Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women | Endo USA Inc., a Keenova Therapeutics Company | Phase 2 | Terminated | Cellulite, Edematous Fibrosclerotic Panniculopathy (EFP) | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04209530) |
| November 20, 2019 | NCT04170296 | Real World CCH Study in Adult Females With Cellulite | Endo USA Inc., a Keenova Therapeutics Company | Phase 3 | Completed | Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite | 153 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04170296) |
| September 17, 2019 | NCT04093050 | Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers | Endo USA Inc., a Keenova Therapeutics Company | Phase 1 | Completed | Healthy Volunteer Safety Study | 41 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04093050) |
| March 28, 2019 | NCT03893890 | Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women | Endo USA Inc., a Keenova Therapeutics Company | Observational | Completed | Edematous Fibrosclerotic Panniculopathy | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03893890) |
| September 18, 2018 | NCT03675685 | Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP | Endo USA Inc., a Keenova Therapeutics Company | Phase 1 | Completed | Edematous Fibrosclerotic Panniculopathy | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03675685) |
| August 16, 2018 | NCT03632993 | Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite) | Endo USA Inc., a Keenova Therapeutics Company | Phase 2 | Completed | Edematous Skin | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03632993) |
| May 16, 2018 | NCT03526549 | Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite) | Endo USA Inc., a Keenova Therapeutics Company | Phase 3 | Completed | Edematous Fibrosclerotic Panniculopathy, Cellulite | 483 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03526549) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 6 |
| Phase 1/2 | 2 |
| Phase 2 | 24 |
| Phase 2/3 | 2 |
| Phase 3 | 48 |
| Phase 4 | 12 |
| Observational | 13 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 88 |
| Terminated | 15 |
| Recruiting | 2 |
| Withdrawn | 1 |
| Suspended | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Cellulite | 18 |
| Dupuytren Contracture | 10 |
| Penile Induration | 9 |
| Chronic Pain | 7 |
| Pain | 6 |
| Pain, Postoperative | 5 |
| Hypogonadism | 4 |
| Neoplasms | 4 |
| Bursitis | 4 |
| Prostatic Neoplasms | 3 |
| Acute Pain | 3 |
| Non-Muscle Invasive Bladder Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Acromegaly | 3 |
| Contracture | 3 |
| Osteoarthritis, Knee | 3 |
| Low Back Pain | 3 |
| Fibromatosis, Plantar | 3 |
| Migraine Disorders | 3 |
| HIV Infections | 2 |
| Cutis Laxa | 2 |
| Carcinoma in Situ | 2 |
| Eunuchism | 2 |
| Carpal Tunnel Syndrome | 2 |
| Neuralgia, Postherpetic | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Buffet restaurants in the United States](https://specstream.ai/data/businesses/buffet-restaurants/united-states)
- [B2B equipment maintenance and repair companies in the United States](https://specstream.ai/data/businesses/b2b-equipment-maintenance-and-repair-companies/united-states)
- [Woodworking supply stores in the United States](https://specstream.ai/data/businesses/woodworking-supply-stores/united-states)
- [Trailer repair shops in the United States](https://specstream.ai/data/businesses/trailer-repair-shops/united-states)
- [Social security law firms in the United States](https://specstream.ai/data/businesses/social-security-law-firms/united-states)
- [Public health clinics in the United States](https://specstream.ai/data/businesses/public-health-clinics/united-states)
